Evidence map›Paper›PMID 41221390›Full record

ArticleWorld journal of nuclear medicine2025

Improving Equitable Cancer Treatment in Australia: The Case for Theranostics in the Northern Territory.

Joshua J Morigi, Suzanne McGavin

Abstract read
In one paragraph

Article in World journal of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Theranostics Implementation: Opportunities and Challenges.World journal of nuclear medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua J MorigiMolecular Imaging Unit, Medical Imaging Service, Royal Darwin Hospital, 105 Rocklands Drive, TIWI, Northern Territory, Australia.
Suzanne McGavinMolecular Imaging Unit, Medical Imaging Service, Royal Darwin Hospital, 105 Rocklands Drive, TIWI, Northern Territory, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Northern Territory (NT) of Australia is a large, low-density territory with the highest percentage of First Nations people in Australia, many of whom live remotely and encounter difficulties and barriers to accessing services. This determines significant gap in healthcare delivery inclusive of Nuclear Medicine and theranostic therapy services. In particular, no theranostic service for cancer patients is currently available in the NT. A narrative retrospective analysis of the provision of nuclear medicine services within the NT at the Royal Darwin Hospital was undertaken to determine the suitability and relevance of the establishment of a new theranostic service within the NT, catered to the specific needs of the local population and in particular of the large proportion of First Nations Patients that are likely to benefit from the local service. Building on the preexisting structure of Nuclear Medicine and PET, inclusive of a comprehensive facility with local production of radiopharmaceuticals, it is expected that the implementation of a theranostic service within the NT will have a high intake and a flow-down positive effect on cancer care within the NT. The implementation of cultural safety principles within the department is embedded in our model of service provision and will further be implemented in the theranostic service delivery. A theranostic service within the NT will prove beneficial to the NT population and sustainable financially. Principles of Cultural safety are paramount to service provision in the NT, and will hopefully contribute to enhancing the experience and improving the outcomes for First Nations patients.

Indexed as

cancer-carecultural-safetymolecular-imagingnuclear-medicinetheranostic

Identifiers

PMID41221390
PMCPMC12602072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.